tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Exagen reports Q4 EPS (20c), consensus (19c)
PremiumThe FlyExagen reports Q4 EPS (20c), consensus (19c)
13d ago
Exagen sees FY26 revenue $70M-$73M, consensus $73.84M
Premium
The Fly
Exagen sees FY26 revenue $70M-$73M, consensus $73.84M
13d ago
Is XGN a Buy, Before Earnings?
Premium
Pre-Earnings
Is XGN a Buy, Before Earnings?
16d ago
Exagen: Temporary Headwinds, Strong AVISE Volume, and Undervalued Long‑Term Upside Support Buy Rating and $15 Target
PremiumRatingsExagen: Temporary Headwinds, Strong AVISE Volume, and Undervalued Long‑Term Upside Support Buy Rating and $15 Target
2M ago
Exagen Announces Record 2025 Revenue and Strong Cash Position
Premium
Company Announcements
Exagen Announces Record 2025 Revenue and Strong Cash Position
2M ago
Exagen: Sustained Test Volume Growth and Solid Cash Runway Support Outperform Rating Despite Mixed Quarter
Premium
Ratings
Exagen: Sustained Test Volume Growth and Solid Cash Runway Support Outperform Rating Despite Mixed Quarter
2M ago
Exagen price target raised to $15 from $13 at BTIG
PremiumThe FlyExagen price target raised to $15 from $13 at BTIG
4M ago
Exagen price target raised to $18 from $15 at B. Riley
Premium
The Fly
Exagen price target raised to $18 from $15 at B. Riley
5M ago
Exagen Inc. Reports Strong Q3 2025 Performance
Premium
Company Announcements
Exagen Inc. Reports Strong Q3 2025 Performance
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100